FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2308455762> ?p ?o ?g. }

• W2308455762 endingPage "953" @default.
• W2308455762 startingPage "945" @default.
• W2308455762 abstract "Mounting evidence indicates that Roux-en-Y gastric bypass (RYGB) ameliorates type 2 diabetes, but randomised trials comparing surgical vs nonsurgical care are needed. With a parallel-group randomised controlled trial (RCT), we compared RYGB vs an intensive lifestyle and medical intervention (ILMI) for type 2 diabetes, including among patients with a BMI <35 kg/m(2).By use of a shared decision-making recruitment strategy targeting the entire at-risk population within an integrated community healthcare system, we screened 1,808 adults meeting inclusion criteria (age 25-64, with type 2 diabetes and a BMI 30-45 kg/m(2)). Of these, 43 were allocated via concealed, computer-generated random assignment in a 1:1 ratio to RYGB or ILMI. The latter involved ≥45 min of aerobic exercise 5 days per week, a dietitian-directed weight- and glucose-lowering diet, and optimal diabetes medical treatment for 1 year. Although treatment allocation could not be blinded, outcomes were determined by a blinded adjudicator. The primary outcome was diabetes remission at 1 year (HbA1c <6.0% [<42.1 mmol/mol], off all diabetes medicines).Twenty-three volunteers were assigned to RYGB and 20 to ILMI. Of these, 11 withdrew before receiving any intervention. Hence 15 in the RYGB group and 17 in the IMLI group were analysed throughout 1 year. The groups were equivalent regarding all baseline characteristics, except that the RYGB cohort had a longer diabetes duration (11.4 ± 4.8 vs 6.8 ± 5.2 years, p = 0.009). Weight loss at 1 year was 25.8 ± 14.5% vs 6.4 ± 5.8% after RYGB vs ILMI, respectively (p < 0.001). The ILMI exercise programme yielded a 22 ± 11% increase in [Formula: see text] (p<0.0001), whereas [Formula: see text] after RYGB was unchanged. Diabetes remission at 1 year was 60.0% with RYGB vs 5.9% with ILMI (p = 0.002). The HbA1c decline over 1 year was only modestly more after RYGB than ILMI: from 7.7 ± 1.0% (60.7 mmol/mol) to 6.4 ± 1.6% (46.4 mmol/mol) vs 7.3 ± 0.9% (56.3 mmol/mol) to 6.9 ± 1.3% (51.9 mmol/mol), respectively (p = 0.04); however, this drop occurred with significantly fewer or no diabetes medications after RYGB. No life-threatening complications occurred.Compared with the most rigorous ILMI yet tested against surgery in a randomised trial, RYGB yielded greater type 2 diabetes remission in mild-to-moderately obese patients recruited from a well-informed, population-based sample.ClinicalTrials.gov NCT01295229." @default.
• W2308455762 created "2016-06-24" @default.
• W2308455762 creator A5011038806 @default.
• W2308455762 creator A5033594203 @default.
• W2308455762 creator A5035816844 @default.
• W2308455762 creator A5042111745 @default.
• W2308455762 creator A5047866821 @default.
• W2308455762 creator A5064847832 @default.
• W2308455762 creator A5066606742 @default.
• W2308455762 creator A5067578562 @default.
• W2308455762 creator A5081005361 @default.
• W2308455762 creator A5082431837 @default.
• W2308455762 creator A5089583678 @default.
• W2308455762 date "2016-03-17" @default.
• W2308455762 modified "2023-10-14" @default.
• W2308455762 title "Gastric bypass surgery vs intensive lifestyle and medical intervention for type 2 diabetes: the CROSSROADS randomised controlled trial" @default.
• W2308455762 cites W1558000543 @default.
• W2308455762 cites W1957007052 @default.
• W2308455762 cites W1970208941 @default.
• W2308455762 cites W1987640886 @default.
• W2308455762 cites W1988329614 @default.
• W2308455762 cites W1994419452 @default.
• W2308455762 cites W1994424586 @default.
• W2308455762 cites W1997594107 @default.
• W2308455762 cites W1999414774 @default.
• W2308455762 cites W2028913390 @default.
• W2308455762 cites W2046439249 @default.
• W2308455762 cites W2046457193 @default.
• W2308455762 cites W2057194981 @default.
• W2308455762 cites W2066885372 @default.
• W2308455762 cites W2080193565 @default.
• W2308455762 cites W2088828925 @default.
• W2308455762 cites W2093587125 @default.
• W2308455762 cites W2097950056 @default.
• W2308455762 cites W2100758175 @default.
• W2308455762 cites W2102264538 @default.
• W2308455762 cites W2103955681 @default.
• W2308455762 cites W2104183837 @default.
• W2308455762 cites W2105725047 @default.
• W2308455762 cites W2107640386 @default.
• W2308455762 cites W2108519858 @default.
• W2308455762 cites W2110791445 @default.
• W2308455762 cites W2125239733 @default.
• W2308455762 cites W2138592519 @default.
• W2308455762 cites W2144631980 @default.
• W2308455762 cites W2147872784 @default.
• W2308455762 cites W2151025825 @default.
• W2308455762 cites W2158822657 @default.
• W2308455762 cites W2172193326 @default.
• W2308455762 cites W2608243249 @default.
• W2308455762 cites W4302127682 @default.
• W2308455762 doi "https://doi.org/10.1007/s00125-016-3903-x" @default.
• W2308455762 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4826815" @default.
• W2308455762 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26983924" @default.
• W2308455762 hasPublicationYear "2016" @default.
• W2308455762 type Work @default.
• W2308455762 sameAs 2308455762 @default.
• W2308455762 citedByCount "234" @default.
• W2308455762 countsByYear W23084557622016 @default.
• W2308455762 countsByYear W23084557622017 @default.
• W2308455762 countsByYear W23084557622018 @default.
• W2308455762 countsByYear W23084557622019 @default.
• W2308455762 countsByYear W23084557622020 @default.
• W2308455762 countsByYear W23084557622021 @default.
• W2308455762 countsByYear W23084557622022 @default.
• W2308455762 countsByYear W23084557622023 @default.
• W2308455762 crossrefType "journal-article" @default.
• W2308455762 hasAuthorship W2308455762A5011038806 @default.
• W2308455762 hasAuthorship W2308455762A5033594203 @default.
• W2308455762 hasAuthorship W2308455762A5035816844 @default.
• W2308455762 hasAuthorship W2308455762A5042111745 @default.
• W2308455762 hasAuthorship W2308455762A5047866821 @default.
• W2308455762 hasAuthorship W2308455762A5064847832 @default.
• W2308455762 hasAuthorship W2308455762A5066606742 @default.
• W2308455762 hasAuthorship W2308455762A5067578562 @default.
• W2308455762 hasAuthorship W2308455762A5081005361 @default.
• W2308455762 hasAuthorship W2308455762A5082431837 @default.
• W2308455762 hasAuthorship W2308455762A5089583678 @default.
• W2308455762 hasBestOaLocation W23084557621 @default.
• W2308455762 hasConcept C126322002 @default.
• W2308455762 hasConcept C134018914 @default.
• W2308455762 hasConcept C141071460 @default.
• W2308455762 hasConcept C168563851 @default.
• W2308455762 hasConcept C1862650 @default.
• W2308455762 hasConcept C2777180221 @default.
• W2308455762 hasConcept C2779400339 @default.
• W2308455762 hasConcept C2908647359 @default.
• W2308455762 hasConcept C3019402062 @default.
• W2308455762 hasConcept C511355011 @default.
• W2308455762 hasConcept C544821477 @default.
• W2308455762 hasConcept C555293320 @default.
• W2308455762 hasConcept C71924100 @default.
• W2308455762 hasConcept C72563966 @default.
• W2308455762 hasConcept C99454951 @default.
• W2308455762 hasConceptScore W2308455762C126322002 @default.
• W2308455762 hasConceptScore W2308455762C134018914 @default.
• W2308455762 hasConceptScore W2308455762C141071460 @default.
• W2308455762 hasConceptScore W2308455762C168563851 @default.

• next